Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

After a long journey, the WHITE-13 DECI Trial is now open to recruitment! This is a randomised clinical trial investigating if an infusion of the anti-TNF agent infliximab during surgery, has an effect on delirium symptoms in the immediate post-operative period and on the development of cognitive impairment, quality of life and mortality in the following year. 

The first site - John Radcliffe Hospital Oxford, opened to recruitment on 22May2024.